MedTrace Logo

Frailty Assessments for Risk Assessment in Gynecologic Oncology Patients

NCT05738252 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 280

Last updated 2025-04-16

No results posted yet for this study

Summary

FARGO is a prospective cohort study that aims to determine the performance of preoperative frailty assessment based on the Frailty Phenotype (FP), compared to a perioperative cardiovascular risk assessment based on the combination of preoperative Revised Cardiac Risk Index (RCRI), age and occurrence of myocardial injury after noncardiac surgery (MINS), in predicting the composite of all-cause death or new disability at 6 months after surgery in patients aged 55 or older. Patients will have confirmed or suspected gynecologic cancer, undergoing cytoreductive or high-risk surgery with or without chemotherapy.

Conditions

Interventions

DIAGNOSTIC_TEST

Clinical Frailty Scale

A way to summarize the overall level of fitness or frailty of an older adult after they had been evaluated by an experienced clinician

DIAGNOSTIC_TEST

Frailty Phenotype

Defined by the presence of three from the following five clinical features: weakness, slow walking speed, unintentional weight loss, exhaustion, and low physical activity

Sponsors & Collaborators

  • Population Health Research Institute

    lead OTHER

Principal Investigators

  • Maura Marcucci, MD · Population Health Research Institute

Eligibility

Min Age
55 Years
Max Age
110 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-15
Primary Completion
2025-05-31
Completion
2025-10-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05738252 on ClinicalTrials.gov